Cite
HARVARD Citation
Tada, T. et al. (2020). Platelet–lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib. European journal of gastroenterology & hepatology. 32 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tada, T. et al. (2020). Platelet–lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib. European journal of gastroenterology & hepatology. 32 (2), p. . [Online].